Enoxaparin for the Prevention of Placental‐Mediated Complications of Pregnancy in Women With Obstetric History or Abnormal Uterine Artery Doppler at First Trimester Ultrasound and Without Thrombophilia: a Multicenter Randomized Controlled Trial

Trial Profile

Enoxaparin for the Prevention of Placental‐Mediated Complications of Pregnancy in Women With Obstetric History or Abnormal Uterine Artery Doppler at First Trimester Ultrasound and Without Thrombophilia: a Multicenter Randomized Controlled Trial

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Jan 2017

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Abruptio placentae; Embolism and thrombosis; Placental disorders; Preeclampsia; Pregnancy complications
  • Focus Therapeutic Use
  • Acronyms HOPPE
  • Most Recent Events

    • 20 Dec 2016 Status changed from active, no longer recruiting to completed.
    • 03 Nov 2016 Planned End Date changed from 1 Sep 2016 to 1 Nov 2016.
    • 07 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Sep 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top